HomeREGULATORY
REGULATORY

CSIMC Recommends NHI Price Listing for 15 APIs/20 Products
(Sep.7.2011)

At a general meeting on September 7, the Central Social Insurance Medical Council (CSIMC; Chuikyo) recommended NHI price listing for 15 APIs (active pharmaceutical ingredients)/20 products, including AstraZeneca’s proton pump inhibitor (PPI) Nexium capsule 10 mg and 20 mg (esomeprazole magnesium) and Astellas Pharma’s treatment for overactive bladder Betanis Tablet 25 mg and 50 mg (mirabegron). The adrenal hormone preparation EpiPen Injection 0.15 mg and 0.3 mg (adrenaline) will be added to the NHI price list on September 22. Other products will be included in the NHI price list on September 12.
> Read full story

Commentary

Japan Compassionate Use System a “Stick” for Drug Makers? Incentives to Counter Their Burden Needed

Lexicon

Z2 Rule:
Z2(ゼットツー)

The Column

The Mastery of Recruitment

Archives

LDP, Komeito Lawmakers’ Group Formed to Fight Hepatitis(Jul.02)
FPMAJ Chair Hails Innovation-Fueling Policies in Govt Fiscal Plan(Jul.02)
JCR Aims at Growth through New Products, Out-Licensing Activities(Jul.02)
JPMA Announces New Fair Competition Guidelines(Jul.02)
Drug Pricing Tomorrow: Full Interview with Ex-Chuikyo Chairman Endo(Jul.02)

News Calendar